Skip to content

Cohort study, 2011

What is the economic burden of moderate to severe PMS or PMDD in Latin American women?

Moderate to severe PMS or PMDD costs an average of 1,618 Brazilian reals per woman per year and causes increasing impairment in work and daily activities as symptom severity increases.

Early or limited evidence Women with moderate to severe PMS or PMDD across four Latin American countries

What they did

Model-based analysis of data from women with moderate to severe PMS or PMDD across four Latin American countries. Women were categorized by symptom severity. Costs, work productivity impact, and quality of life effects were measured.

What they found

Average annual cost per patient was 1,618 Brazilian reals with a 95 percent confidence interval of 957 to 2,481. Disease burden on work and daily activities consistently increased with disease severity. The relationship between cost and quality of life was less clear.

What it means for you

PMS and PMDD have real economic costs and significantly affect ability to work and do daily tasks, especially when symptoms are severe. Costs are based on Brazilian private healthcare, so they may not reflect costs in other countries or healthcare systems.

1,618 BRL

Average annual cost per woman

4

Latin American countries studied

957-2,481

Cost range (95% confidence interval)

About the study

Original title
The burden of moderate/severe premenstrual syndrome and premenstrual dysphoric disorder in a cohort of Latin American women
Authors
Schiola A, Lowin J, Lindemann M et al.
Journal
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Year
2011
Study design
Cohort study
What was tested
None (cost and burden analysis)
Open access
Yes

Topics